Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
NHS Solutions
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn More
Insight & Feedback
Insight & Feedback (desc)
Costing Solutions
Costing Solutions (desc)
Clinical Coding Analytics
Clinical Coding Analytics (desc)
Benchmarking
Benchmarking (desc)
Analytics
Analytics (desc)
Pathway Transformation
Pathway Transformation (desc)
AppScript
AppScript (desc)
Securnet
Securnet (desc)
Life Sciences Industry
We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn More
Advancing UK Healthcare
We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
Pharmacy Communications
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn More
The IQVIA difference
Explore IQVIA by region
As a global community, IQVIA continuously invests and commits to advancing human health.
Americas
Europe
Asia & Oceania
Middle East & Africa
EMEA Thought Leadership
Video
Integrated Care Systems: an opportunity to improve Patient and Market Access at a local level
May 09, 2022
- Locations
- United Kingdom
- Integrated Care Systems: an opportunity to improve Patient and Market Access at a local level
Watch our latest webinar with PharmaPhorum on 26 April 2022, where our expert panellists provided key intelligence into the PESHTEL analysis of the UK market access environment and the importance of collaboration between ICS leaders to address system readiness to improve population health.